Adam Hoye-Simek, PharmD, RPH is the Senior Pharmacy Manager of Utilization Management for Devoted Health Plan. Devoted Health provides innovative Medicare Advantage in 13 states across the country and has been the fastest-growing Medicare Advantage plan in the country for multiple years. Adam oversees the organization’s pharmacy-related benefits that fall under Part B. He leads clinical strategy, CMS auditing, appeals, and manages the day-to-day operations for the department. He has exclusively written and maintained the department's library of over 30 coverage policies. He led the company’s implementation of biosimilar-focused step therapy and continues to lead preferred drug and durable medical equipment strategies. Adam is the company's subject matter expert for the billing and coding of medical drugs and related devices and oversees the external relationships with third-party vendors. Adam is currently serving as a key stakeholder in his organization's implementation of the Inflation Reduction Act of 2022 and the CMS 2024 Final Rule change. He is also heavily involved in cross-benefit (medical and pharmacy) strategy and proper benefit adjudication. Adam has been an active AMCP member since 2019. He has served on AMCP's Format for Formulary Submissions Committee since early 2022 and is on the Digital Therapeutics subcommittee. He also serves as an AMCP State Advocacy Leader for the state of Massachusetts and has recently been invited to participate in AMCP’s Biologics and Biosimilars Collective Intelligence Consortium.